Foot And Mouth Disease Vaccine Market Size, Share & Trends Analysis Report By Animal (Cattle, Sheep & Goat, Swine), By Vaccine (Modified/Attenuated Live), By Distribution Channel, By Region, And Segment Forecasts, 2026

Description

The global foot and mouth disease vaccine market was valued at USD 2.7 billion in 2025 and is projected to grow from USD 2.9 billion in 2026 to USD 5.1 billion in 2033, at a CAGR of approximately 8.8% from 2026 to 2033. The Asia Pacific dominated the market, accounting for a revenue share of 45.0% in 2025. The increasing livestock population and demand for animal products are significant factors contributing to market growth. In addition, with rapid globalization and climate change, livestock diseases have been increasing over the past few decades. To ensure safe healthcare practices for companion animals and livestock, the government has undertaken various initiatives and programs. Thereby, contributing to the growth of the veterinary vaccine market, of which foot and mouth disease (FMD) vaccines capture a significant share.

The growing human population has driven the demand for animal products such as milk, chicken, eggs, and meat. Vaccines help minimize animal loss and ensure their safety, which is likely to drive market growth over the forecast period. The increasing production and consumption of milk and milk products in countries such as India are further expected to contribute to market growth.

In developing countries, livestock is a contributor to GDP; hence, there is increasing demand for efficient animal healthcare practices, which is expected to drive growth in this market over the forecast period. For instance, in July 2024, according to information published by the Ministry of Finance (India), 4.6% of total GVA in 2022-23 was contributed by the livestock sector, thereby boosting the per capita availability of milk, eggs, and meat. The livestock population has increased rapidly owing to the adoption of advanced medication and vaccination programs to maintain livestock health.

Various government initiatives and programs have boosted growth in this market. According to the Food and Agriculture Organization of the U.S. and the World Organization for Animal Health, SEACFMD 2021-2025 was launched to increase productivity and economic output in the livestock sector by managing and eradicating FMD, thereby enhancing food security and supporting rural smallholder farmers. Investments made by government institutions have supported the production of FMD vaccines and boosted the market growth.

Global Foot And Mouth Disease Vaccine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global foot and mouth disease vaccine market report based on animal, vaccine, distribution channel, and region:

Animal Outlook (Revenue, USD Billion, 2021 - 2033)

Cattle

Sheep and Goat

Swine

Others

Vaccine Outlook (Revenue, USD Billion, 2021 - 2033)

Modified/ Attenuated Live

Inactivated (Killed)

Other Vaccines

Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)

Veterinary Hospitals & Clinics

Government Institutions

Others

Regional Outlook (Revenue, USD Billion, 2021 - 2033)

Europe

Russia
France

Asia Pacific

Japan
China
India
South Korea
Indonesia
Thailand

Latin America

Brazil
Argentina

MEA

South Africa
Saudi Arabia
UAE
Kuwait
Egypt
Turkey

Product Code: GVR-1-68038-656-1

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Foot & Mouth Disease Vaccine Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Foot & Mouth Disease Vaccine Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Foot & Mouth Disease Vaccine Market: Animal Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Foot & Mouth Disease Vaccine Market: Animal Movement Analysis, 2025 & 2033 (USD Million)
4.3. Cattle
- 4.3.1. Cattle Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Sheep and Goat
- 4.4.1. Sheep and Goat Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Swine
- 4.5.1. Swine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Others
- 4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Foot & Mouth Disease Vaccine Market: Vaccine Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Foot & Mouth Disease Vaccine Market: Vaccine Movement Analysis, 2025 & 2033 (USD Million)
5.3. Modified/ Attenuated Live
- 5.3.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Inactivated (Killed)
- 5.4.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Other Vaccines (DNA vaccines, Peptide vaccines)
- 5.5.1. Other Vaccines (DNA vaccines, Peptide vaccines) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Foot & Mouth Disease Vaccine Market: Distribution Channel Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Foot & Mouth Disease Vaccine Market: Distribution Channel Movement Analysis, 2025 & 2033 (USD Million)
6.3. Veterinary Hospitals & Clinics
- 6.3.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Government Institutions
- 6.4.1. Government Institutions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Others
- 6.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Foot & Mouth Disease Vaccine Market: Regional Estimates & Trend Analysis

7.1. Foot & Mouth Disease Vaccine Market Share, By Region, 2025 & 2033 (USD Million)
7.2. Europe
- 7.2.1. Europe Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.2.2. Russia
  - 7.2.2.1. Russia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.2.3. France
  - 7.2.3.1. France Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3. Asia Pacific
- 7.3.1. Asia Pacific Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. Japan
  - 7.3.2.1. Japan Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. China
  - 7.3.3.1. China Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.4. India
  - 7.3.4.1. India Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.5. South Korea
  - 7.3.5.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.6. Indonesia
  - 7.3.6.1. Indonesia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.7. South Korea
  - 7.3.7.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.8. Thailand
  - 7.3.8.1. Thailand Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Latin America
- 7.4.1. Latin America Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.2. Brazil
  - 7.4.2.1. Brazil Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Argentina
  - 7.4.3.1. Argentina Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Middle East and Africa
- 7.5.1. Middle East and Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. South Africa
  - 7.5.2.1. South Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Saudi Arabia
  - 7.5.3.1. Saudi Arabia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. UAE
  - 7.5.4.1. Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Kuwait
  - 7.5.5.1. Kuwait Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Egypt
  - 7.5.6.1. Egypt Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Turkey
  - 7.5.7.1. Turkey Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
- 8.4.1. Merck & Co., Inc.
  - 8.4.1.1. Participant's Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. Biogenesis Bago
  - 8.4.2.1. Participant's Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. Zoetis Inc.
  - 8.4.3.1. Participant's Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Boehringer Ingelheim International GmbH
  - 8.4.4.1. Participant's Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. Indian Immunologicals Limited
  - 8.4.5.1. Participant's Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Bayer AG
  - 8.4.6.1. Participant's Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. Hester Biosciences Limited
  - 8.4.7.1. Participant's Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
  - 8.4.8.1. Participant's Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. Brilliant Bio Pharma Limited
  - 8.4.9.1. Participant's Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Recent Developments/ Strategic Initiatives
- 8.4.10. Biovet Private Ltd
  - 8.4.10.1. Participant's Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Recent Developments/ Strategic Initiatives

Foot And Mouth Disease Vaccine Market Size, Share & Trends Analysis Report By Animal (Cattle, Sheep & Goat, Swine), By Vaccine (Modified/Attenuated Live), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033